ACOG Stock Analysis: Buy, Sell, or Hold?
ACOG - Alpha Cognition Inc. Common Stock
$9.75
0.25 (2.63%)
▲
5d:
+10.29%
30d:
+18.47%
90d:
+67.53%
HOLD
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When ACOG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ACOG is 7.5% above its trading range ($9.07). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ACOG is 7.5% above its trading range ($9.07). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: ACOG is currently trading at $9.75, which is considered extended relative to its 30-day fair value range of $8.21 to $9.07.
Technical Outlook: Technically, ACOG is in a strong uptrend. Immediate support is located at $8.20, while resistance sits at $10.10.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (16th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.00 (+84.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ACOG is in a strong uptrend. Immediate support is located at $8.20, while resistance sits at $10.10.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (16th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.00 (+84.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$8.21 -
$9.07
Company Quality Score
53/100
(HOLD)
Options IV Signal
16th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range (+7.5% above its trading range)
- BULLISH: Options cheap (IV 16th percentile)
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 84.6% below Wall St target ($18.00)
- NEUTRAL: Bottoming setup forming (43/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$8.21 -
$9.07
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.82
(8.4%)
Support & Resistance Levels
Support Level
$8.20
Resistance Level
$10.10
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.73
Wall Street Target
$18.00
(+84.6%)
Revenue Growth (YoY)
267.6%
Profit Margin
-155.5%
Share & Embed Analysis
Last updated: August 24, 2026 9:20 AM ET
Data refreshes hourly during market hours. Next update: 10:20 AM
Data refreshes hourly during market hours. Next update: 10:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACOG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$370 | 42 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 27 SELL |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$560 | 30 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$313 | 51 HOLD |
